Cutaneous Manifestations of Dermatomyositis and Their Management

@article{Callen2010CutaneousMO,
  title={Cutaneous Manifestations of Dermatomyositis and Their Management},
  author={Jeffrey P. Callen},
  journal={Current Rheumatology Reports},
  year={2010},
  volume={12},
  pages={192-197}
}
  • J. Callen
  • Published 14 April 2010
  • Medicine
  • Current Rheumatology Reports
Dermatomyositis is a condition with pathognomonic and characteristic cutaneous lesions. This article describes the skin manifestations observed in patients with dermatomyositis, their differential diagnosis, their relationship to internal disease (particularly malignancy), and their management. 
Panniculitis as an Initial Presentation of Dermatomyositis: A Case Report
TLDR
A case of dermatomyositis in 37 years old female who presented with only panniculitis and the diagnosis was delayed by more than a year is reported. Expand
A report of seronegative clinically amyopathic dermatomyositis
TLDR
A case of seronegative CADM in a young female athlete is reported and a high index of suspicion is imperative to minimize rheumatologic and dermatologic misdiagnoses. Expand
Koebner Phenomenon in Juvenile Dermatomyositis
Koebner phenomenon is an isomorphic response seen in a variety of dermatoses such as psoriasis. Its key feature is the appearance of a new dermatosis in previously unaffected areas following trauma.Expand
Skin manifestation in dermatomyositis
Dermatomyositis (DM) is a systemic autoimmune disorder with skin, muscle involvement, and other manifestations including polyarthritis, interstitial lung fibrosis, and, in 20–25 % of the cases, aExpand
Management of cutaneous dermatomyositis
TLDR
A paucity of controlled studies in this disease leads to limitations in interpreting the available data, and an algorithmic approach to treatment of skin disease is presented. Expand
Two fatal cases of dermatomyositis and ovarian cancer
TLDR
The importance of a proactive approach to the management of ovarian cancer in adult female DM patients is highlighted and two cases are presented to highlight the importance of this approach. Expand
Dermatomyositis: An Update on Diagnosis and Treatment
TLDR
Diagnosis is discussed, with a focus on myositis-specific antibodies and their associated phenotypes, and therapies available for this often refractory skin disease are reviewed. Expand
Itchy Facial Rash
  • Yan Ling Kong, E. Y. Gan
  • Medicine
  • Pediatric Autoimmunity and Transplantation
  • 2019
TLDR
The most common MSA present in JDM are the anti-p155/140 autoantibodies and Methotrexate is the most common steroid-sparing oral immunosuppressant used in the treatment of juvenile dermatomyositis. Expand
Autoimmune and Connective Tissue Disease in Skin of Color
TLDR
In ethnic groups, disease burden at presentation, severity of disease, prognosis, and disease-specific mortality have been shown to differ between ethnicities, as well when compared to Caucasian populations. Expand
Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review
TLDR
DM subforms are discussed, focusing on their dermatological manifestations that can be classified as pathognomonic, characteristic, compatible, less common, rare, recently-described, and non-specific skin lesions. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 25 REFERENCES
The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis
TLDR
This data indicates that modulation of cutaneous inflammation in the setting of collagen vascular disease by type I interferon‐associated recruitment of CXCR3+ lymphocytes in dermatomyositis is dependent on the carrier status of these lymphocytes. Expand
Topical tacrolimus treatment in a patient with dermatomyositis.
TLDR
Cutaneous lesions may be the major manifestation of the disease, making it difficult to justify systemic agents because of their side effects, and administration of systemic agents leads in many cases to remission of the cutaneous lesions. Expand
Polymyositis and dermatomyositis (first of two parts).
(First of Two Parts) POLYMYOSITIS is an inflammatory myopathy of unknown cause to which the term dermatomyositis is applied in the presence of the characteristic skin rash. These disorders shareExpand
Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects
TLDR
Cutaneous features of dermatomyositis strongly suggest that ultraviolet (UV) radiation plays an important role in the pathogenesis of the disease, and the UVB minimal erythema dose (MED) in DM patients in comparison with those in lupus ery thematosus (LE) and healthy controls is investigated. Expand
Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.
TLDR
It is concluded that hydroxychloroquine may have a role as an adjuvant to the therapy of patients with cutaneous lesions of DM. Expand
Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis.
TLDR
It is described the first use of rapamycin in a young patient with dermatomyositis, and high-dose steroids may adversely impair treatment of these malignancies. Expand
Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed.
TLDR
Recognition of this process is important because scalp involvement is often overlooked, may be misdiagnosed initially, and can be the presenting complaint in some patients with dermatomyositis. Expand
Dermatomyositis: A Clinicopathological Study of 40 Patients
TLDR
It is suggested that acute cutaneous lesions of SLE cannot be distinguished from DM, and clinicopathologic correlation is important for making a diagnosis of DM or SLE. Expand
Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis
TLDR
A 54-year-old woman presented with a facial rash, joint pains, generalised weakness and breathlessness, and had Gottron's sign, mechanic's hands, a heliotropic rash and weakness in her quadriceps grade 3 and neck muscles grade 4, on a five-point system. Expand
Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed.
TLDR
Recognition of this process is important because scalp involvement is often overlooked, may be misdiagnosed initially, and can be the presenting complaint in some patients with dermatomyositis. Expand
...
1
2
3
...